Edit with
Browse our active clinical trials. Filter by condition to find studies that may be right for you. Each study links to ClinicalTrials.gov for full eligibility details.
Status
Condition
Evaluating the combination of eltrekibart and mirikizumab in adults with Ulcerative Colitis.
Sponsor
Lilly
Phase
Phase 2
Studying elafibranor in adults with Primary Biliary Cholangitis who had an inadequate response or intolerance to ursodeoxycholic acid.
Sponsor
Ipsen
Phase
Phase 3
A long-term study evaluating the safety and effectiveness of elafibranor in adults with Primary Biliary Cholangitis (PBC).
Sponsor
Ipsen
Phase
Phase 3
Comparing vonoprazan 20mg against placebo in adults with Eosinophilic Esophagitis.
Sponsor
Phathom Pharmaceuticals
Phase
Phase 2
Evaluating survodutide in patients with NASH/MASH and cirrhosis.
Sponsor
Boehringer Ingelheim
Phase
Phase 3
Evaluating VE303 for the prevention of recurrent Clostridioides difficile infection.
Sponsor
Vedanta Biosciences
Phase
Phase 3
Evaluating whether resmetirom improves clinical outcomes in patients with well-compensated NASH cirrhosis.
Sponsor
Madrigal Pharmaceuticals
Phase
Phase 3
Evaluating tirzepatide in patients with Psoriatic Arthritis who are overweight or obese, following treatment with ixekizumab.
Sponsor
Lilly
Phase
Phase 4
Evaluating survodutide in patients with NASH/MASH and moderate or advanced liver fibrosis.
Sponsor
Boehringer Ingelheim
Phase
Phase 3
Evaluating tulisokibart in adults with Psoriatic Arthritis.
Sponsor
Merck Sharp & Dohme (MSD)
Phase
Phase 2
All studies at ICR are 100% voluntary and overseen by an independent Institutional Review Board (IRB). You may withdraw at any time, for any reason, without penalty. Study statuses and eligibility criteria change over time — always refer to the linked ClinicalTrials.gov page for the most current information.